Evaluating the Effectiveness of Switching to Insulin Degludec from Other Basal Insulins in a Real-World Canadian Population with Type 1 or Type 2 Diabetes: The CAN-TREAT Study

INTRODUCTION: The aim of the study was to examine glycaemic control and safety of insulin degludec (degludec) in patients with either type 1 diabetes (T1D) or type 2 diabetes (T2D) under routine care settings in Canada. METHODS: Data were extracted from medical records of adults with T1D or T2D who...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Stewart B., Ajala, Olubukola, Bari, Basel, Liutkus, Joanne, Hahn, Jina, Martyn, Oliver, Zwicker, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179881/
https://www.ncbi.nlm.nih.gov/pubmed/33932223
http://dx.doi.org/10.1007/s13300-021-01063-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179881/
https://www.ncbi.nlm.nih.gov/pubmed/33932223
http://dx.doi.org/10.1007/s13300-021-01063-5

Ejemplares similares